← Open Payments lookup

JOHN STAHLMAN: Open Payments

NPI 1811006273 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,663 in 92 payments from 13 companies in 2025. Trend: 2023 $993 · 2024 $971 · 2025 $1,663

Food & beverage: $1,663
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.32$484
Neurocrine BioSciences, Inc.12$240
ABBVIE INC.15$221
E.R. Squibb & Sons, L.L.C.7$162
Otsuka America Pharmaceutical, Inc.6$115
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$92
Vanda Pharmaceuticals Inc.4$91
Axsome Therapeutics, Inc.3$87
Janssen Pharmaceuticals, Inc3$57
Alkermes, Inc.3$48

Products named: AUSTEDO XR, INGREZZA, VRAYLAR, COBENFY, UZEDY, REXULTI, CAPLYTA, FANAPT.

Industry payments across NC — which companies pay providers there.